AVTR
Avantor, Inc.
Next earnings Jul 30, 2026 (before open) · consensus $0.19 EPS, $1.64B rev
Last earnings -0.1% on 2026-04-29
$10.32
▲ +2.89%$10.32▼ -23.73%
over 1Y
L $7.41H $15.60
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+2.9%
1W+2.4%
1M+14.8%
3M+30.6%
YTD-9.9%
1Y-23.7%
Hold
Conviction
Horizon
Medium (3–12mo)
12-mo target
$•••
Street · 25 analysts
Hold
Lab-supplies turnaround: GAAP loss is a non-cash goodwill writedown, but organic sales are still shrinking and leverage is high.
Net income -$530M · FY2025
Avantor is a life-sciences and lab-products supplier in the midst of a difficult turnaround. The FY2025 headline net loss of $530M looks alarming, but the MD&A clarifies that it was primarily driven by a $785M non-cash goodwill impairment on the Distribution reporting unit — a charge management attributes to a 'sustained decrease in our publicly quoted share price and market capitalization' rather than an operating collapse. Stripping that out, the business remains profitable on an adjusted basis: Adjusted EBITDA was $1.07B and Adjusted Operating Income $957.8M, and operating cash flow stayed positive at $624M. So this is not a broken business — but it is a deteriorating one.
The operating trends are genuinely weak. Revenue fell 3.4% to $6.55B (organic -2.8%), continuing a multi-year slide from $7.51B in FY2022 as biopharma destocking and soft lab demand persist. Gross margin slipped to 32.7%, and the company carries significant leverage — long-term debt rose 21.0% to $3.92B, which it refinanced in Q4 2025 with new euro term loans and an expanded revolver. The management response is a 'cost transformation initiative' targeting ~$400M of run-rate gross savings by end-2027, and a new CEO (Emmanuel Ligner, ex-Cytiva/Danaher) took over in August 2025 — a credible operator for a productivity-led turnaround.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 21, 2026, 4:55 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Financials · annual, by fiscal year
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $7.39B | $7.51B | $6.97B | $6.78B | $6.55B |
| Gross profit | $2.50B | $2.60B | $2.36B | $2.28B | $2.14B |
| Operating income | $972M | $1.13B | $696M | $1.08B | -$246M |
| Net income | $573M | $687M | $321M | $712M | -$530M |
| Diluted EPS | $0.85 | $1.01 | $0.47 | $1.04 | -$0.78 |
| Net margin | 7.8% | 9.1% | 4.6% | 10.5% | -8.1% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value$10.6B
EV / EBITDA64.8
EV / Sales1.6
EV / FCF21.5
P / FCF14.2
PEG (trailing)—
Earnings yield-7.5%
FCF yield7.0%
Quality & risk
ROIC (est.)-2.0%
Free cash flow$495M
Total debt$3.95B
Net cash-$3.58B
Altman Z-Score1.47 distress
Piotroski F-Score3/9
Capital returns
Buyback yield1.1%
Dividend yield (est.)—
Shareholder yield1.1%
Shares Δ YoY+0.2%
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosure timeline
SEC · 8-Ks + reportsSome governance/structural items recently, but no outright red flags.
Recent filings
all on EDGAR ↗4Period ending 2026-06-212026-06-22open ↗SDFiling2026-05-29open ↗8-KPeriod ending 2026-05-072026-05-12open ↗4Period ending 2026-05-072026-05-11open ↗4Period ending 2026-05-072026-05-11open ↗4Period ending 2026-05-072026-05-11open ↗4Period ending 2026-05-072026-05-11open ↗4Period ending 2026-05-072026-05-11open ↗4Period ending 2026-05-072026-05-11open ↗4Period ending 2026-05-072026-05-11open ↗4Period ending 2026-05-072026-05-11open ↗4Period ending 2026-05-012026-05-05open ↗
Frequently asked
- Is Avantor, Inc. (AVTR) a buy?
- AVTR currently carries a Hold rating with 2/5 conviction, derived from its latest SEC filings. Lab-supplies turnaround: GAAP loss is a non-cash goodwill writedown, but organic sales are still shrinking and leverage is high.
- What is Avantor, Inc.'s quality score?
- AVTR scores 45.947801467392694/100 (grade D) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0001722482, latest 10-Q filed 2026-04-29) · EODHD · Proprietary analysis · as of 6/21/2026, 8:55:52 PM.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.